These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

422 related items for PubMed ID: 15183323

  • 21. [Strategy of molecular drug design: hits, leads and drug candidates].
    Guo ZR.
    Yao Xue Xue Bao; 2008 Sep; 43(9):898-904. PubMed ID: 19048779
    [Abstract] [Full Text] [Related]

  • 22. Mass spectrometric techniques for label-free high-throughput screening in drug discovery.
    Roddy TP, Horvath CR, Stout SJ, Kenney KL, Ho PI, Zhang JH, Vickers C, Kaushik V, Hubbard B, Wang YK.
    Anal Chem; 2007 Nov 01; 79(21):8207-13. PubMed ID: 17902631
    [Abstract] [Full Text] [Related]

  • 23. Complex phenotypic assays in high-throughput screening.
    Clemons PA.
    Curr Opin Chem Biol; 2004 Jun 01; 8(3):334-8. PubMed ID: 15183333
    [Abstract] [Full Text] [Related]

  • 24. Design strategies for building drug-like chemical libraries.
    Mitchell T, Showell GA.
    Curr Opin Drug Discov Devel; 2001 May 01; 4(3):314-8. PubMed ID: 11560064
    [Abstract] [Full Text] [Related]

  • 25. Importance of molecular computer modeling in anticancer drug development.
    Geromichalos GD.
    J BUON; 2007 Sep 01; 12 Suppl 1():S101-18. PubMed ID: 17935268
    [Abstract] [Full Text] [Related]

  • 26. Process technologies for purity enhancement of large discovery libraries.
    Pottorf RS, Player MR.
    Curr Opin Drug Discov Devel; 2004 Nov 01; 7(6):777-83. PubMed ID: 15595438
    [Abstract] [Full Text] [Related]

  • 27. Selective optimization of side activities: another way for drug discovery.
    Wermuth CG.
    J Med Chem; 2004 Mar 11; 47(6):1303-14. PubMed ID: 14998318
    [No Abstract] [Full Text] [Related]

  • 28. Current directions in the evolution of compound libraries.
    Webb TR.
    Curr Opin Drug Discov Devel; 2005 May 11; 8(3):303-8. PubMed ID: 15892244
    [Abstract] [Full Text] [Related]

  • 29. Molecular complexity and fragment-based drug discovery: ten years on.
    Leach AR, Hann MM.
    Curr Opin Chem Biol; 2011 Aug 11; 15(4):489-96. PubMed ID: 21665521
    [Abstract] [Full Text] [Related]

  • 30. Property distributions: differences between drugs, natural products, and molecules from combinatorial chemistry.
    Feher M, Schmidt JM.
    J Chem Inf Comput Sci; 2003 Aug 11; 43(1):218-27. PubMed ID: 12546556
    [Abstract] [Full Text] [Related]

  • 31. 'Metabolite-likeness' as a criterion in the design and selection of pharmaceutical drug libraries.
    Dobson PD, Patel Y, Kell DB.
    Drug Discov Today; 2009 Jan 11; 14(1-2):31-40. PubMed ID: 19049901
    [Abstract] [Full Text] [Related]

  • 32. Structure-based generation of viable leads from small combinatorial libraries.
    Laird ER, Blake JF.
    Curr Opin Drug Discov Devel; 2004 May 11; 7(3):354-9. PubMed ID: 15216940
    [Abstract] [Full Text] [Related]

  • 33. Emerging chemical patterns: a new methodology for molecular classification and compound selection.
    Auer J, Bajorath J.
    J Chem Inf Model; 2006 May 11; 46(6):2502-14. PubMed ID: 17125191
    [Abstract] [Full Text] [Related]

  • 34. Lead optimization in the nondrug-like space.
    Zhao H.
    Drug Discov Today; 2011 Feb 11; 16(3-4):158-63. PubMed ID: 21147254
    [Abstract] [Full Text] [Related]

  • 35. CLEVER: pipeline for designing in silico chemical libraries.
    Song CM, Bernardo PH, Chai CL, Tong JC.
    J Mol Graph Model; 2009 Jan 11; 27(5):578-83. PubMed ID: 18986817
    [Abstract] [Full Text] [Related]

  • 36. Novel trends in high-throughput screening.
    Mayr LM, Bojanic D.
    Curr Opin Pharmacol; 2009 Oct 11; 9(5):580-8. PubMed ID: 19775937
    [Abstract] [Full Text] [Related]

  • 37. A web-based platform for virtual screening.
    Watson P, Verdonk M, Hartshorn MJ.
    J Mol Graph Model; 2003 Sep 11; 22(1):71-82. PubMed ID: 12798392
    [Abstract] [Full Text] [Related]

  • 38. High-throughput screening-driven lead discovery: meeting the challenges of finding new therapeutics.
    Posner BA.
    Curr Opin Drug Discov Devel; 2005 Jul 11; 8(4):487-94. PubMed ID: 16022185
    [Abstract] [Full Text] [Related]

  • 39. Computational chemistry approaches to drug discovery in signal transduction.
    Fischer PM.
    Biotechnol J; 2008 Apr 11; 3(4):452-70. PubMed ID: 18412174
    [Abstract] [Full Text] [Related]

  • 40. Natural product-like synthetic libraries.
    Thomas GL, Johannes CW.
    Curr Opin Chem Biol; 2011 Aug 11; 15(4):516-22. PubMed ID: 21684804
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.